Study wrapper · #731
Reduced serum and skeletal muscle MOTS c levels in women with polycystic ovary syndrome are associated with mitochondrial dysfunction.
Editor's note
This case-control study found that women with PCOS had lower circulating MOTS-c (220 vs 498 pg/mL) and lower skeletal-muscle MOTS-c than matched controls, with serum levels inversely associated with testosterone and cholesterol. The muscle-biopsy confirmation adds a compartment-level dimension beyond blood. Still, this is observational: 40 versus 40 participants, cross-sectional, so direction and causation are unresolved. Notably it points the opposite way to an adolescent PCOS study reporting no significant MOTS-c difference, underscoring genuine mixed signals in the MOTS-c/PCOS literature. Weight it as a plausible association, MOTS-c is reduced in this adult PCOS sample, that needs larger, prospective confirmation before any interpretive weight is placed on it.
Plain-language abstract
Polycystic ovary syndrome (PCOS) often involves insulin resistance and disturbed metabolism. Researchers measured MOTS-c, a mitochondria-derived peptide tied to how muscle and cells use glucose, in 40 women with PCOS and 40 similar women without it. Blood MOTS-c was markedly lower in the PCOS group (about 220 versus 498 units), and, in a subset who had muscle biopsies, MOTS-c was also lower in the muscle tissue itself. Lower blood MOTS-c went along with higher testosterone and cholesterol. Because everyone was measured at a single time, the study cannot show whether low MOTS-c contributes to PCOS or simply reflects it. It is also worth noting that a separate study in teenagers found no clear MOTS-c difference in PCOS, so the overall picture is mixed. The authors call for larger studies. For now this suggests MOTS-c may be reduced in adult PCOS, a lead worth confirming rather than a settled fact.